By David Khalaf
on July 11, 2019
One of the aspects of cannabidiol (CBD) sales that can attract regulatory scrutiny is the way in which merchants market their CBD products. In the past five years, the FDA has sent many warning letters to manufacturers and merchants of CBD products for claims that their products can prevent, cure, mitigate, or treat diseases. No…
By LegitScript Folks
on June 27, 2019
We’re happy to announce a new certification program for legally compliant CBD products and websites. Starting today, US manufacturers and merchants can apply through LegitScript to certify CBD products and websites that are in compliance with USDA, FDA, FTC, and DEA regulations, as well as state-specific laws. LegitScript is the global leader in merchant and…
By Domenica Beall
on June 18, 2019
As e-commerce platforms, payment service providers, and regulatory agencies crack down on illicit opioid sales on the internet, many consumers are turning to alternative products, either to replicate the effects of opioids or to aid in opioid withdrawal. Many of these products, however, are unregulated, illegal, and potentially dangerous. LegitScript analysts have recently identified a…
on May 31, 2019
CVS announced in May a new policy that requires all vitamins and dietary supplements in the store to be third-party tested for safety and label accuracy. The “Tested to Be Trusted” program is an innovative initiative to weed out problematic supplements, but will it create new problems for e-commerce platforms and payment service providers operating…
on May 24, 2019
CBD merchant accounts are still difficult for CBD producers, merchants, and retailers to get, despite the passage of the 2018 Farm Bill, which legalized hemp and hemp-derived CBD with THC levels of no more than 0.3 percent. Why are payment service providers still wary about onboarding CBD merchants? The answer lies in the fact that…